Anti-complement factor BB antibodies and uses thereof
US10934347B2 · kind B2 · utility
4Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2017 |
| Grant date | Mar 2, 2021 |
| Priority date | — |
| Expiry date | Oct 6, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-mediated disorders. The present disclosure provides methods of treating complement-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.